This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Feb;18(1):28-9.

doi: 10.1136/eb-2012-100755. Epub 2012 Jun 27.

Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications

Maria T DeSancho¹, Stephen M Pastores

Affiliations

PMID: 22740355
DOI: 10.1136/eb-2012-100755

Comment

Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications

Maria T DeSancho et al. Evid Based Med. 2013 Feb.

. 2013 Feb;18(1):28-9.

doi: 10.1136/eb-2012-100755. Epub 2012 Jun 27.

Authors

Maria T DeSancho¹, Stephen M Pastores

Affiliation

¹ Department of Medicine, Weill Cornell Medical Center, New York, New York 10021, USA. mtd2002@med.cornell.edu

PMID: 22740355
DOI: 10.1136/eb-2012-100755

No abstract available

PubMed Disclaimer

Comment on

Treatment for superficial thrombophlebitis of the leg.
Di Nisio M, Wichers IM, Middeldorp S. Di Nisio M, et al. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD004982. doi: 10.1002/14651858.CD004982.pub4. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004982. doi: 10.1002/14651858.CD004982.pub5. PMID: 22419302 Updated.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.